Brainstorm Cell Therapeutics In

Q2 2018 13F Holders

Symbol
BCLI
CUSIP
10501E201
Type
Equity
Class
COM NEW
Num filings
41
Total reported value, excl. options
$9.49 M
Manager Report Date Value ($000) Shares Option Type